Burova; Elena
Patent Applications and Registrations
Patent applications and USPTO patent grants for Burova; Elena.The latest application filed is for "human antibodies to pd-l1".
- Burova; Elena - Mount Kisco NY
| Patent | Date |
|---|---|
| Human Antibodies To Pd-l1 App 20210380702 - Papadopoulos; Nicholas J. ; et al. | 2021-12-09 |
| Non-human Animals Having A Humanized Lymphocyte-activation Gene 3 App 20210360908 - Mujica; Alexander O. ; et al. | 2021-11-25 |
| Human antibodies to PD-L1 Grant 11,117,970 - Papadopoulos , et al. September 14, 2 | 2021-09-14 |
| Non-human animals having a humanized lymphocyte-activation gene 3 Grant 11,102,961 - Mujica , et al. August 31, 2 | 2021-08-31 |
| Genetically Modified Mouse Whose Genome Comprises A Humanized Cd274 Gene App 20210105983 - Burova; Elena ; et al. | 2021-04-15 |
| Anti-CTLA-4 Antibodies and Uses Thereof App 20210040232 - HERMANN; Aynur ; et al. | 2021-02-11 |
| Genetically modified mouse whose genome comprises a humanized CD274 gene Grant 10,881,086 - Burova , et al. January 5, 2 | 2021-01-05 |
| Anti-CTLA-4 antibodies and uses thereof Grant 10,844,137 - Hermann , et al. November 24, 2 | 2020-11-24 |
| Human Antibodies To Pd-1 App 20200330794 - Papadopoulos; Nicholas J. ; et al. | 2020-10-22 |
| Human antibodies to PD-1 Grant 10,737,113 - Papadopoulos , et al. A | 2020-08-11 |
| Non-human Animals Having A Humanized Programmed Cell Death 1 Gene App 20200053992 - Burova; Elena ; et al. | 2020-02-20 |
| Methods and compositions comprising a combination of a VEGF antagonist and an anti-CTLA-4 antibody Grant 10,532,096 - Ioffe , et al. Ja | 2020-01-14 |
| Non-human Animals Having A Humanized Lymphocyte-activation Gene 3 App 20190320632 - Mujica; Alexander O. ; et al. | 2019-10-24 |
| Anti-lag3 Antibodies And Uses Thereof App 20190284277 - ULLMAN; Erica ; et al. | 2019-09-19 |
| Non-human animals having a humanized programmed cell death 1 gene Grant 10,390,522 - Burova , et al. A | 2019-08-27 |
| Anti-LAG3 antibodies and uses thereof Grant 10,358,495 - Ullman , et al. | 2019-07-23 |
| Non-human animals having a humanized lymphocyte-activation gene 3 Grant 10,306,874 - Mujica , et al. | 2019-06-04 |
| Anti-CTLA-4 Antibodies and Uses Thereof App 20190048096 - HERMANN; Aynur ; et al. | 2019-02-14 |
| Methods And Compositions Comprising A Combination Of A Vegf Antagonist And An Anti-ctla-4 Antibody App 20180236070 - IOFFE; Ella ; et al. | 2018-08-23 |
| Non-human Animals Having A Humanized Programmed Cell Death 1 Gene App 20180206462 - Burova; Elena ; et al. | 2018-07-26 |
| Human Antibodies To Pd-l1 App 20180186883 - PAPADOPOULOS; Nicholas J. ; et al. | 2018-07-05 |
| Human Antibodies To Pd-1 App 20180185668 - PAPADOPOULOS; Nicholas J. ; et al. | 2018-07-05 |
| Genetically Modified Mouse Whose Genome Comprises A Humanized Cd274 Gene App 20180160663 - Burova; Elena ; et al. | 2018-06-14 |
| Human antibodies to PD-1 Grant 9,987,500 - Papadopoulos , et al. June 5, 2 | 2018-06-05 |
| Methods and compositions comprising a combination of a VEGF Trap and an anti-CTLA-4 antibody Grant 9,968,674 - Ioffe , et al. May 15, 2 | 2018-05-15 |
| Human antibodies to PD-L1 Grant 9,938,345 - Papadopoulos , et al. April 10, 2 | 2018-04-10 |
| Genetically modified mouse whose genome comprises a humanized CD274 gene Grant 9,913,461 - Burova , et al. March 13, 2 | 2018-03-13 |
| Non-human Animals Having A Humanized Lymphocyte-activation Gene 3 App 20170142943 - Mujica; Alexander O. ; et al. | 2017-05-25 |
| Anti-LAG3 Antibodies and Uses Thereof App 20170101472 - ULLMAN; Erica ; et al. | 2017-04-13 |
| Methods And Compositions Comprising A Combination Of A Vegf Antagonist And An Anti-ctla-4 Antibody App 20160243225 - IOFFE; Ella ; et al. | 2016-08-25 |
| Non-human Animals Having A Humanized Cluster Of Differentiation 274 Gene App 20160157469 - Burova; Elena ; et al. | 2016-06-09 |
| Non-human Animals Having A Humanized Programmed Cell Death 1 Gene App 20150366174 - BUROVA; Elena ; et al. | 2015-12-24 |
| Human Antibodies to PD-L1 App 20150203580 - Papadopoulos; Nicholas J. ; et al. | 2015-07-23 |
| Human Antibodies to PD-1 App 20150203579 - Papadopoulos; Nicholas J. ; et al. | 2015-07-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 